Navigation Links
Rosetta Genomics Reports First Quarter 2008 Financial Results
Date:5/21/2008

d development, net $ 6,400 $ 4,781 $ 2,389 $ 1,161

Marketing and business

development 1,742 1,504 511 375

General and administrative 2,903 1,860 829 680

Operating loss 11,045 8,145 3,729 2,216

Financial expenses (income),

net 3,616 (538) 149 (200)

Net loss $ 14,661 $ 7,607 $ 3,878 $ 2,016

Basic and diluted net loss

per Ordinary share $ 1.32 $ 2.98 $ 0.33 $ 0.23

Weighted average number of

Ordinary shares used to

compute basic and diluted

net loss per Ordinary share 11,142,149 2,551,860 11,920,401 8,874,841

Contact: Media

Rachel Spielman

T: +1-212-583-2714

E: media@rosettagenomics.com

Investors

Ron Kamienchick

T: +1-646-509-1893

E: investors@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... Two champions of science, technology, engineering, ... an annual competition for middle and high school students ... STEM study. The competition presents students with real-world problems ... Aptitude, Mathematics, and Sciences is a program administered ...
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... Ltd. (Amex: SVA ), a,leading developer and provider of ... and nine-month periods ended,September 30, 2008. , , ... year-over-year to $34.1 million, -- Operating income year-to-date ... million, -- Net income year-to-date maintained at same ...
... experience in multi-GPU high-performance computing systems designed ... scientists, engineers and researchers with a GPU-based ... (PSC), which will be shown at the ... Conference, the top international conference for high ...
... Performance of Bioinformatics Application. Part of "Project GreenLight" Energy ... ... (PRWEB) November 17, 2008 -- Convey Computer Corporation today announced ... computer, the Convey HC-1, to the University of California, San ...
Cached Biology Technology:Sinovac Reports Third Quarter 2008 Unaudited Financial Results 2Sinovac Reports Third Quarter 2008 Unaudited Financial Results 3Sinovac Reports Third Quarter 2008 Unaudited Financial Results 4Sinovac Reports Third Quarter 2008 Unaudited Financial Results 5Sinovac Reports Third Quarter 2008 Unaudited Financial Results 6Sinovac Reports Third Quarter 2008 Unaudited Financial Results 7Sinovac Reports Third Quarter 2008 Unaudited Financial Results 8Sinovac Reports Third Quarter 2008 Unaudited Financial Results 9Sinovac Reports Third Quarter 2008 Unaudited Financial Results 10Sinovac Reports Third Quarter 2008 Unaudited Financial Results 11Sinovac Reports Third Quarter 2008 Unaudited Financial Results 12Sinovac Reports Third Quarter 2008 Unaudited Financial Results 13Sinovac Reports Third Quarter 2008 Unaudited Financial Results 14Sinovac Reports Third Quarter 2008 Unaudited Financial Results 15Sinovac Reports Third Quarter 2008 Unaudited Financial Results 16BOXX Personal Supercomputer for Research Scientists Featured at SC08 2Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference 2Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference 3Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference 4Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference 5
(Date:4/17/2014)... ALBUQUERQUE, N.M. A credit-card-sized anthrax detection cartridge developed ... small business makes testing safer, easier, faster and cheaper. ... causes anthrax, is commonly found in soils all over ... illness in both humans and animals. The bacteria can ... to B. anthracis may occur through skin ...
(Date:4/17/2014)... bone marrow need to produce hydrogen sulfide in order ... a new study from the Center for Craniofacial Molecular ... USC. , Professor Songtao Shi, principal investigator on the ... the cells governs the flow of calcium ions. The ... results in osteogenesis, or the creation of new bone ...
(Date:4/17/2014)... and pathogens that devastate honeybees in Europe, Asia and ... do not appear to be impacting native honeybee populations ... researchers., The invasive pests include including Nosema microsporidia ... honeybees appear to be resilient to these invasive pests, ... control pests in Europe, Asia and the United States ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
... March 21, 2011 Aware, Inc. (Nasdaq: AWRE ... that it will demonstrate several enhanced software modules for its ... at the upcoming IP&TV World Forum which will take place ... demonstrated include LDP,s DSL Service Predictor and Health Monitor. ...
... Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have developed a ... gene as an informant. Published online today in Nature Genetics, ... systematically explore the very large part of our genome that ... large role in making each of us unique, by controlling ...
... mounds left by prehistoric humans might have driven the formation ... of exceptional ecological richness in the sprawling marsh that are ... of relatively high and dry ground that dot the marshes ... high, many of them are elevated enough to allow trees ...
Cached Biology News:Aware to Showcase DSL Test Solutions for IPTV Services at IP&TV World Forum 2Aware to Showcase DSL Test Solutions for IPTV Services at IP&TV World Forum 3The informant: a jumping gene 2Ancient trash heaps gave rise to Everglades tree islands 2
Evolutionarily conserved signaling intermediate in Toll pathway...
Amino-acids and Derivatives Rabbit Anti-conjugated L-isoleucine Polyclonal Antibody...
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Biology Products: